CN113234742A - Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes - Google Patents
Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes Download PDFInfo
- Publication number
- CN113234742A CN113234742A CN202110540431.7A CN202110540431A CN113234742A CN 113234742 A CN113234742 A CN 113234742A CN 202110540431 A CN202110540431 A CN 202110540431A CN 113234742 A CN113234742 A CN 113234742A
- Authority
- CN
- China
- Prior art keywords
- gene
- ferulic acid
- esterase
- expression vector
- dffae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010041969 feruloyl esterase Proteins 0.000 title claims description 29
- 230000000694 effects Effects 0.000 title description 29
- 238000002360 preparation method Methods 0.000 title description 4
- 239000002154 agricultural waste Substances 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 101001065065 Aspergillus awamori Feruloyl esterase A Proteins 0.000 claims abstract description 28
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 20
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 20
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 20
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 20
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000013604 expression vector Substances 0.000 claims abstract description 19
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 238000003259 recombinant expression Methods 0.000 claims abstract description 18
- 241000894006 Bacteria Species 0.000 claims abstract description 15
- AUJXJFHANFIVKH-GQCTYLIASA-N trans-methylferulate Chemical compound COC(=O)\C=C\C1=CC=C(O)C(OC)=C1 AUJXJFHANFIVKH-GQCTYLIASA-N 0.000 claims abstract description 14
- 241000588724 Escherichia coli Species 0.000 claims abstract description 11
- 238000010353 genetic engineering Methods 0.000 claims abstract description 7
- JTLOUXXZZFFBBW-UHFFFAOYSA-N isoferulic acid methyl ester Natural products COC(=O)C=CC1=CC=C(OC)C(O)=C1 JTLOUXXZZFFBBW-UHFFFAOYSA-N 0.000 claims abstract description 7
- AUJXJFHANFIVKH-UHFFFAOYSA-N methyl cis-ferulate Natural products COC(=O)C=CC1=CC=C(O)C(OC)=C1 AUJXJFHANFIVKH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108090000790 Enzymes Proteins 0.000 claims description 35
- 102000004190 Enzymes Human genes 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- NITWSHWHQAQBAW-QPJJXVBHSA-N (E)-4-coumaric acid methyl ester Chemical compound COC(=O)\C=C\C1=CC=C(O)C=C1 NITWSHWHQAQBAW-QPJJXVBHSA-N 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 238000000338 in vitro Methods 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 239000013613 expression plasmid Substances 0.000 claims description 5
- 150000007965 phenolic acids Chemical class 0.000 claims description 5
- JHLPYWLKSLVYOI-UHFFFAOYSA-N trans-Sinapic acid methylester Natural products COC(=O)C=CC1=CC(OC)=C(O)C(OC)=C1 JHLPYWLKSLVYOI-UHFFFAOYSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- BPHPUYQFMNQIOC-MBOVONDJSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-propan-2-ylsulfanyloxane-3,4,5-triol Chemical compound CC(C)SC1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-MBOVONDJSA-N 0.000 claims description 3
- 241001052560 Thallis Species 0.000 claims description 3
- 238000001042 affinity chromatography Methods 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000035939 shock Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 238000002270 exclusion chromatography Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 abstract description 6
- 108090000604 Hydrolases Proteins 0.000 abstract description 2
- 239000002299 complementary DNA Substances 0.000 abstract description 2
- 210000003608 fece Anatomy 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 34
- 238000006243 chemical reaction Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- DVDUMIQZEUTAGK-UHFFFAOYSA-N p-nitrophenyl butyrate Chemical compound CCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 DVDUMIQZEUTAGK-UHFFFAOYSA-N 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002808 molecular sieve Substances 0.000 description 4
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- GGIDEJQGAZSTES-UHFFFAOYSA-N (4-nitrophenyl) octanoate Chemical compound CCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 GGIDEJQGAZSTES-UHFFFAOYSA-N 0.000 description 3
- YBADLXQNJCMBKR-UHFFFAOYSA-M (4-nitrophenyl)acetate Chemical compound [O-]C(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-M 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241001143779 Dorea Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VIQDYVAKUJDZBD-YCRREMRBSA-N (4-nitrophenyl) (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)OC=2C=CC(=CC=2)[N+]([O-])=O)=C1 VIQDYVAKUJDZBD-YCRREMRBSA-N 0.000 description 2
- JXRYDOZRPYFBKO-UHFFFAOYSA-N 3,4-dimethoxy-cinnamic acidmethyl ester Natural products COC(=O)C=CC1=CC=C(OC)C(OC)=C1 JXRYDOZRPYFBKO-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229930005346 hydroxycinnamic acid Natural products 0.000 description 2
- 235000010359 hydroxycinnamic acids Nutrition 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- OCNYGKNIVPVPPX-HWKANZROSA-N methyl caffeate Chemical compound COC(=O)\C=C\C1=CC=C(O)C(O)=C1 OCNYGKNIVPVPPX-HWKANZROSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 2
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- YHPHXKZGZHPYME-UHFFFAOYSA-N 2-propan-2-yl-2h-thiopyran Chemical compound CC(C)C1SC=CC=C1 YHPHXKZGZHPYME-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 1
- RXTBLQVXNIECFP-FXQIFTODSA-N Ala-Gln-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RXTBLQVXNIECFP-FXQIFTODSA-N 0.000 description 1
- FBHOPGDGELNWRH-DRZSPHRISA-N Ala-Glu-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FBHOPGDGELNWRH-DRZSPHRISA-N 0.000 description 1
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 1
- HJGZVLLLBJLXFC-LSJOCFKGSA-N Ala-His-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O HJGZVLLLBJLXFC-LSJOCFKGSA-N 0.000 description 1
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- WEZNQZHACPSMEF-QEJZJMRPSA-N Ala-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 WEZNQZHACPSMEF-QEJZJMRPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 1
- BZWRLDPIWKOVKB-ZPFDUUQYSA-N Asn-Leu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BZWRLDPIWKOVKB-ZPFDUUQYSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- CASGONAXMZPHCK-FXQIFTODSA-N Asp-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N CASGONAXMZPHCK-FXQIFTODSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- ZXRQJQCXPSMNMR-XIRDDKMYSA-N Asp-Lys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N ZXRQJQCXPSMNMR-XIRDDKMYSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KABHAOSDMIYXTR-GUBZILKMSA-N Cys-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N KABHAOSDMIYXTR-GUBZILKMSA-N 0.000 description 1
- CVLIHKBUPSFRQP-WHFBIAKZSA-N Cys-Gly-Ala Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(O)=O CVLIHKBUPSFRQP-WHFBIAKZSA-N 0.000 description 1
- SRIRHERUAMYIOQ-CIUDSAMLSA-N Cys-Leu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SRIRHERUAMYIOQ-CIUDSAMLSA-N 0.000 description 1
- LWYKPOCGGTYAIH-FXQIFTODSA-N Cys-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N LWYKPOCGGTYAIH-FXQIFTODSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241001531200 Dorea formicigenerans Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- VZRAXPGTUNDIDK-GUBZILKMSA-N Gln-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VZRAXPGTUNDIDK-GUBZILKMSA-N 0.000 description 1
- RONJIBWTGKVKFY-HTUGSXCWSA-N Gln-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O RONJIBWTGKVKFY-HTUGSXCWSA-N 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 1
- ALOBJFDJTMQQPW-ONGXEEELSA-N Gly-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CN ALOBJFDJTMQQPW-ONGXEEELSA-N 0.000 description 1
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 1
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- DFHVLUKTTVTCKY-PBCZWWQYSA-N His-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N)O DFHVLUKTTVTCKY-PBCZWWQYSA-N 0.000 description 1
- IMPKSPYRPUXYAP-SZMVWBNQSA-N His-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CN=CN3)N IMPKSPYRPUXYAP-SZMVWBNQSA-N 0.000 description 1
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- MSASLZGZQAXVFP-PEDHHIEDSA-N Ile-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N MSASLZGZQAXVFP-PEDHHIEDSA-N 0.000 description 1
- RQZFWBLDTBDEOF-RNJOBUHISA-N Ile-Val-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N RQZFWBLDTBDEOF-RNJOBUHISA-N 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 description 1
- IBSGMIPRBMPMHE-IHRRRGAJSA-N Leu-Met-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O IBSGMIPRBMPMHE-IHRRRGAJSA-N 0.000 description 1
- UIIMIKFNIYPDJF-WDSOQIARSA-N Leu-Trp-Met Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)[C@@H](N)CC(C)C)=CNC2=C1 UIIMIKFNIYPDJF-WDSOQIARSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- JCFYLFOCALSNLQ-GUBZILKMSA-N Lys-Ala-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JCFYLFOCALSNLQ-GUBZILKMSA-N 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 1
- SQJSXOQXJYAVRV-SRVKXCTJSA-N Lys-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N SQJSXOQXJYAVRV-SRVKXCTJSA-N 0.000 description 1
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 1
- KVNLHIXLLZBAFQ-RWMBFGLXSA-N Lys-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N KVNLHIXLLZBAFQ-RWMBFGLXSA-N 0.000 description 1
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 1
- NSGXXVIHCIAISP-CIUDSAMLSA-N Met-Asn-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O NSGXXVIHCIAISP-CIUDSAMLSA-N 0.000 description 1
- BMHIFARYXOJDLD-WPRPVWTQSA-N Met-Gly-Val Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O BMHIFARYXOJDLD-WPRPVWTQSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- SPXWRYVHOZVYBU-ULQDDVLXSA-N Phe-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=CC=C2)N SPXWRYVHOZVYBU-ULQDDVLXSA-N 0.000 description 1
- YOFKMVUAZGPFCF-IHRRRGAJSA-N Phe-Met-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O YOFKMVUAZGPFCF-IHRRRGAJSA-N 0.000 description 1
- OAAWNUBFRMVIQS-IHPCNDPISA-N Phe-Trp-Cys Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CS)CC1=CNC2=CC=CC=C12)CC1=CC=CC=C1 OAAWNUBFRMVIQS-IHPCNDPISA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- VOZIBWWZSBIXQN-SRVKXCTJSA-N Pro-Glu-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O VOZIBWWZSBIXQN-SRVKXCTJSA-N 0.000 description 1
- ANESFYPBAJPYNJ-SDDRHHMPSA-N Pro-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ANESFYPBAJPYNJ-SDDRHHMPSA-N 0.000 description 1
- CWZUFLWPEFHWEI-IHRRRGAJSA-N Pro-Tyr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O CWZUFLWPEFHWEI-IHRRRGAJSA-N 0.000 description 1
- CJNCVBHTDXKTMJ-CYDGBPFRSA-N Ser-Asp-Lys-Pro Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O CJNCVBHTDXKTMJ-CYDGBPFRSA-N 0.000 description 1
- LPSKHZWBQONOQJ-XIRDDKMYSA-N Ser-Lys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N LPSKHZWBQONOQJ-XIRDDKMYSA-N 0.000 description 1
- VXYQOFXBIXKPCX-BQBZGAKWSA-N Ser-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N VXYQOFXBIXKPCX-BQBZGAKWSA-N 0.000 description 1
- OQSQCUWQOIHECT-YJRXYDGGSA-N Ser-Tyr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OQSQCUWQOIHECT-YJRXYDGGSA-N 0.000 description 1
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UQTNIFUCMBFWEJ-IWGUZYHVSA-N Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-IWGUZYHVSA-N 0.000 description 1
- GKWNLDNXMMLRMC-GLLZPBPUSA-N Thr-Glu-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O GKWNLDNXMMLRMC-GLLZPBPUSA-N 0.000 description 1
- MCDVZTRGHNXTGK-HJGDQZAQSA-N Thr-Met-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O MCDVZTRGHNXTGK-HJGDQZAQSA-N 0.000 description 1
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- JWGXUKHIKXZWNG-RYUDHWBXSA-N Tyr-Gly-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O JWGXUKHIKXZWNG-RYUDHWBXSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 1
- VPEFOFYNHBWFNQ-UFYCRDLUSA-N Tyr-Pro-Tyr Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 VPEFOFYNHBWFNQ-UFYCRDLUSA-N 0.000 description 1
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 1
- MDYSKHBSPXUOPV-JSGCOSHPSA-N Val-Gly-Phe Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MDYSKHBSPXUOPV-JSGCOSHPSA-N 0.000 description 1
- XBRMBDFYOFARST-AVGNSLFASA-N Val-His-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N XBRMBDFYOFARST-AVGNSLFASA-N 0.000 description 1
- DAVNYIUELQBTAP-XUXIUFHCSA-N Val-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N DAVNYIUELQBTAP-XUXIUFHCSA-N 0.000 description 1
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- ZXYPHBKIZLAQTL-QXEWZRGKSA-N Val-Pro-Asp Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N ZXYPHBKIZLAQTL-QXEWZRGKSA-N 0.000 description 1
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 1
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 1
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 108010009297 diglycyl-histidine Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- -1 ferulic acid ester Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000002029 lignocellulosic biomass Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910001432 tin ion Inorganic materials 0.000 description 1
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01073—Feruloyl esterase (3.1.1.73)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a gene for expressing feruloyl esterase, protein coded by the gene, a recombinant expression vector containing the gene, a recombinant genetic engineering bacterium and application thereof, wherein the nucleotide sequence of the gene is shown as SEQ ID NO: 2, respectively. The invention separates a gram-positive obligate anaerobic bacillus-free bacillary bacterium from human feces, screens an amino acid sequence fragment with alpha/beta hydrolase 8 chain center beta folding conformation from a transcriptome library of the bacillary bacterium, reversely transcribes the sequence into cDNA and constructs a recombinant expression vector, successfully expresses heterologously by an escherichia coli host BL21(DE3), purifies a high-concentration and uniform-property target protein, can effectively hydrolyze a model substrate such as methyl ferulate and the like, has the potential of releasing a high value-added product ferulic acid from agricultural residues, and provides a new feasible scheme for industrial application of preparing the ferulic acid by enzymolysis.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and particularly relates to a gene for expressing feruloyl esterase, a protein coded by the gene, a recombinant expression vector containing the gene, a recombinant genetic engineering bacterium and application thereof.
Background
Ferulic Acid (FA) belongs to hydroxycinnamic acid (HGA) in phenolic acid family, is a caffeic acid derivative, and is covalently linked with lignocellulose and other components in plant cell wall through ester bond. Ferulic acid is widely found in vegetables, fruits, herbal medicines and certain beverages such as coffee and beer. The 3-methoxy, 4-hydroxy and carboxyl on the benzene ring enable the ferulic acid to have good oxidation resistance, can effectively remove active oxygen and remove free radicals, and inhibit oxidation reaction caused by ultraviolet rays or radiation, so the ferulic acid is used as a novel antioxidant with strong cell protection activity. Ferulic acid has been used today in the health care and cosmetic industries and has become a potential drug for the treatment of many oxidation related diseases, including alzheimer's disease, cancer, cardiovascular diseases, diabetes and skin diseases, among others.
Lignocellulosic biomass is a currently studied and popular renewable resource that needs to be converted to a low molecular weight carbon source for further utilization. Due to the complex cross-linked network structure, a series of cellulase and hemicellulase are required to act together to degrade the cellulase. Feruloyl esterase (EC 3.1.1.73) can catalyze the hydrolysis of ester bond between hydroxycinnamic acid and backbone glycan, thereby promoting the combination and action of other enzymes and lignocellulose, and releasing ferulic acid with high added value in the process. Compared with the traditional alkaline hydrolysis method, the enzymatic hydrolysis method has higher efficiency and environmental friendliness, has higher specificity, does not damage other valuable chemical substances, and is suitable for industrial production.
The Dorea formicenerans (commercially available from American ATCC germplasm pool: bio-091013 or JCM germplasm pool: bio-104980) related to the invention is a gram-positive obligate anaerobic bacillus-free rod-shaped bacterium separated from human feces. Screening an amino acid sequence fragment with beta-sheet conformation at the 8 chain center of alpha/beta hydrolase from a transcriptome library of the protein has not been reported in any previous literature and is not annotated as ferulic acid esterase. The sequence is reversely transcribed into cDNA and a recombinant expression vector is constructed, preferably escherichia coli host BL21(DE3) is successfully and heterogeneously expressed, the target protein with high concentration and uniform property is purified, the High Performance Liquid Chromatography (HPLC) result shows that the protein can effectively hydrolyze methyl ferulate and other model substrates, the optimal reaction condition of the enzyme is measured and calculated by using a p-nitrobenzene artificial substrate, and then the enzyme is applied to successfully release ferulic acid with high added value from four agricultural residues of DE-starch wheat bran, brewer's grains, corn straws and corncobs, thereby providing a new feasible scheme for the industrial application of preparing ferulic acid by enzymolysis.
Disclosure of Invention
The invention aims to improve the application of the prior art and provides a gene for expressing feruloyl esterase, a protein coded by the gene, a recombinant expression vector containing the gene, a recombinant genetic engineering bacterium and application thereof.
In order to achieve the above object, the present invention provides the following technical solutions:
one of the purposes of the invention is to provide a gene for expressing feruloyl esterase, wherein the nucleotide sequence of the gene is shown as SEQ ID NO: 2, respectively.
The invention also aims to provide a DSFAE protein encoded by the gene for expressing feruloyl esterase, wherein the amino acid sequence of the DSFAE protein is shown as SEQ ID NO: 1 is shown.
The present invention also provides a recombinant expression vector comprising the ferulic acid esterase gene of claim 1.
Further, the recombinant expression vector was obtained by inserting the gene expressing feruloyl esterase between the restriction sites BamHI and XhoI of the expression plasmid pET-28 a.
The fourth purpose of the invention is to provide a recombinant gene engineering bacterium, which is constructed by transforming the recombinant expression vector into an escherichia coli host BL21(DE 3).
The fifth purpose of the invention is to provide the application of the gene for expressing ferulic acid esterase in-vitro expression of DSFAE protein.
Further, the method for expressing the gene of the ferulic acid esterase to express the DSFAE protein in vitro comprises the following specific steps:
(1) cloning to obtain the gene of claim 1, and inserting the gene between enzyme cutting sites BamHI and XhoI of expression plasmid pET-28a (+) to obtain a recombinant expression vector pET-28a (+) -Dffae;
(2) transforming the recombinant expression vector pET-28a (+) -Dffae into competent cells BL21(DE3) through heat shock, and screening to obtain recombinant genetic engineering bacteria;
(3) culturing the genetically engineered bacteria at 37 deg.C, and culturing to obtain bacterial liquid OD600When the value reaches 0.8, cooling to 18 ℃, inducing by using isopropyl thiogalactopyranoside (IPTG) for 14h at 18 ℃, crushing thalli by using a high-pressure homogenization method, and purifying the supernatant of the bacterial liquid by using an affinity chromatography column, an ion column chromatography column and a molecular exclusion chromatography column in sequence to obtain the ferulic acid esterase enzyme liquid.
The sixth purpose of the invention is to provide the application of the gene for expressing the ferulic acid esterase in the production of functional phenolic acid by enzymolysis.
Further, the functional phenolic acid comprises ferulic acid, coumaric acid and sinapic acid, and the raw materials comprise methyl ferulate, methyl coumarate and methyl sinapinate.
Further, the enzymatic production method is to contact the relevant substrate and the protein under the condition of enzymatic reaction, and the condition of enzymatic reaction comprises: the temperature is 20-70 deg.C, pH is 4.5-10.0, and the time is 30 min.
The invention has the advantages that:
(1) the invention expresses the gene sequence of ferulic acid esterase from enterobacteria Dorea formicenerans for the first time in vitro so as to be helpful for researching the functions and regulation mechanism of the protein and have important significance for regulating and controlling the structure of intestinal microflora based on a nutrition strategy to promote human health;
(2) the recombinant expression plasmid of the ferulic acid esterase gene DfFAE is obtained by an in vitro gene cloning technology, can be stably and efficiently expressed after being transferred into escherichia coli, and has the expressed ferulic acid esterase yield of 10mg/mL and the purity of over 95 percent. The ferulic acid esterase produced by the fermentation of the recombinant strain is most suitable for pH8.4, the enzyme activity retention rate is more than 96% after the ferulic acid esterase is treated for 1 hour within the range of pH 8.0-8.4, and the alkali resistance is good; the temperature tolerance is good, the optimum temperature is 40 ℃, and the enzyme activity retention rate is more than 80% after the treatment at 40 ℃ for 6 hours; the metal ions have good tolerance, the sodium ions, the calcium ions and the tin ions can improve the activity of the esterase, and the other metal ions hardly have influence on the enzyme activity of the feruloyl esterase. The invention provides an intestinal flora feruloyl esterase which has good alkali resistance and metal ion tolerance, realizes high-efficiency expression in escherichia coli, has high purity and has very important industrial application value.
Drawings
FIG. 1 is a graph showing the results of HPLC-mode substrate specificity measurement.
FIG. 2 is a diagram showing the results of the measurement of the specificity of the p-nitrobenzene artificial substrate.
FIG. 3 is a graph showing the temperature activity of feruloyl esterase.
FIG. 4 shows pH activity curves and pH tolerance curves of feruloyl esterase.
FIG. 5 is a graph showing the temperature tolerance of feruloyl esterase.
FIG. 6 is a graph showing the results of evaluation of the metal ion and organic solvent resistance of feruloyl esterase.
FIG. 7 shows the fit of the equation of Mie for feruloyl esterase.
FIG. 8 is a graph showing the tendency of feruloyl esterase to hydrolyze different natural substrates to release ferulic acid.
Detailed Description
The technical scheme of the invention is further explained by combining the specific examples as follows:
experimental materials and general experimental methods:
1. bacterial strain and carrier:
escherichia coli (Escherichia coli) Trans1-T1, BL21(DE3) from Beijing Quanjin (TransGen Biotech) Inc., and pET-28a (+) plasmid from Beijing Liuhe Huada Gene technology, Inc.
2. Enzymes and other biochemical reagents:
the tool enzyme comprises restriction enzyme, DNA ligase and Taq enzyme, and the DNA extraction, purification and gel recovery kit is purchased from Takara company. Methyl Ferulate (MFA), methyl p-coumarate (MpCA), Methyl Sinapinate (MSA), and Methyl Caffeate (MCA) were purchased from MERDA. Others are made in China (all can be purchased from common biochemical agents).
3. Culture medium:
(1) liquid LB medium: 10g/L of sodium chloride (NaCl), 10g/L of Tryptone (Tryptone) and 5g/L of Yeast powder (Yeast Extract);
(2) solid LB medium: 10g/L of sodium chloride (NaCl), 10g/L of Tryptone (Tryptone), 5g/L of Yeast powder (Yeast Extract) and 20g/L of Agar (Agar);
sterilizing the above culture medium with high pressure steam at 121 deg.C under 103kPa for 20min, cooling the solid culture medium to about 50 deg.C, and pouring into a super clean bench.
Example 1 E.coli expression of Feruloyl esterase Gene
(1) Amplification of a target gene:
the inventors of the present invention found that a ferulic acid esterase DfFAE derived from Dorea formicenerans (commercially available from American ATCC germplasm pool: bio-091013 or Japanese JCM germplasm pool: bio-104980) has an amino acid sequence shown in SEQ ID NO. 1. The esterase nucleotide sequence obtained by the artificial chemical synthesis method is shown as SEQ ID NO.2, and under the condition that the gene sequence is obtained, the gene can be artificially synthesized by the technical personnel in the field according to the prior gene recombination technology, the technology is mature, the technical personnel in the field can realize the synthesis without creative labor, and the details are not repeated. The two ends of the synthesized Dffae gene are also provided with BamHI and XhoI enzyme cutting sites so as to be convenient for connecting with an expression vector. The Dffae gene is amplified by taking the nucleotide sequence as a template, and the primers are as follows:
DSFAE-F:5’-CGCGGATCCATGAACCAGAAAAAAG-3’
DSFAE-R:5’-CCGCTCGAGTCAGTTGGTGTGTTTC-3’
the BamHI and XhoI sites are underlined, respectively.
(2) Constructing a recombinant expression vector:
the DSFAE gene is subjected to double enzyme digestion by BamHI and XhoI, and then is connected with an expression vector pET-28a (+) subjected to enzyme digestion by BamHI and XhoI, an escherichia coli competent cell T1 is transformed, a recombinant plasmid pET-28a (+) -Dffae is constructed, the recombinant plasmid is coated on an LB (Langmycin) flat plate with kanamycin resistance to screen positive clones, a single colony is selected to be reserved and used as colony PCR (polymerase chain reaction), then the colony PCR is sent to Beijing engine for sequencing, the sequencing result shows that the gene has the full length of 837bp and codes 274 amino acids, the recombinant plasmid contains the Dffae gene, and the positive clone plasmid is extracted for later use.
EXAMPLE 2 isolation and purification of Feruloyl esterase
The recombinant plasmid pET-28a (+) -Dffae constructed by the ferulic acid esterase gene is transformed into an Escherichia coli BL21-Gold (DE3) host by heat shock, and the genetic engineering bacteria for expressing the ferulic acid esterase is constructed. Culturing the above genetically engineered bacteria at 37 deg.C to obtain bacterial liquid OD600When the value reaches 0.8, isopropyl thiopyran galacto-alcohol is used at 18 DEG CGlycoside (IPTG) is induced for 12h, after the thalli are crushed by a high-pressure homogenization method, the supernatant of the bacterial liquid passes through an affinity chromatography column (nickel column), an ion column (Source15Q) and a molecular sieve (Superdex200) in sequence to prepare the ferulic acid esterase enzyme liquid (10.2 mg/ml). The ferulic acid esterase amino acid sequence is numbered WP _117657856 in the NCBI database.
Example 3 measurement of the Activity of purified Feruloyl esterase and evaluation of the enzymatic Properties
1) Determination of substrate specificity of feruloyl esterase
Four modes of substrate specificity were determined by HPLC: the chromatographic conditions were a Waters Atlantis dC18 chromatographic liquid phase column, the column temperature was 25 ℃, and the mobile phase solution was: ultrapure water (0.1% formic acid) and methanol (0.1% formic acid) in the proportions: 0-9.5min, 40: 60 (v/v); 9.5-18min, 85: flow rate of 15 (v/v): 0.5ml/min, the detection wavelength is: 323 nm. Determining the amount of ferulic acid by retention time and peak area using external standard method. The results show (as shown in FIG. 1) that the enzyme has good activity on MFA, MpCA and MSA, and is consistent with the characteristics of the A-type feruloyl esterase described in the prior literature.
The specificity of the p-nitrobenzene artificial substrate is determined by a spectrophotometric method: the enzyme was reacted with four artificial substrates, i.e., p-nitrophenylacetate (pNPA), p-nitrophenylbutyrate (pNPB), p-nitrophenyloctanoate (pNPO) and p-nitrophenylferulate (pNPF), 1. mu.L of the enzyme solution was added to 284. mu.L of a pH 7.0 potassium dihydrogen phosphate-dipotassium hydrogen phosphate buffer solution containing 2.5% Trixton X-100, 10mM 15. mu.L of the substrate was added to initiate the reaction, and OD was measured after 5min at 30 ℃ and OD was measured405The value is obtained. The results show (as shown in fig. 2) that DfFAE has significant activity on pNPA, pNPB and pNPO, and the activity on pNPB is the highest, and then the following operations all use pNPB.
2) pH activity curve of feruloyl esterase
The pH gradient conditions of 5.0, 5.4, 6.0, 7.4, 8.0, 8.4 and 9.0 are set by using a citric acid-sodium citrate buffer solution, a dipotassium hydrogen phosphate-potassium dihydrogen phosphate buffer solution and a boric acid-borax buffer solution, and the activity of the purified ferulic acid esterase is measured. The results show (as shown in figure 4) that the optimum action pH of the enzyme is 8.4, and the relative enzyme activity is above 69% in the range of pH 8.0-9.0.
3) Temperature activity curve of feruloyl esterase
The reaction temperature in the enzyme activity determination process is set to 4 ℃, 25 ℃, 30 ℃, 40 ℃, 50 ℃, 60 ℃ and 70 ℃ respectively, the reaction is carried out for 5min under each gradient condition of the pH8.4 environment, and the activity of the purified ferulic acid ester enzyme is determined. The results show (as shown in figure 3) that the optimal action temperature of the enzyme is 40 ℃, and the relative enzyme activity is above 58% in the range of 25-50 ℃.
4) Assessment of pH stability of Feruloyl esterase
Diluting the original enzyme solution by 3 times with a molecular sieve buffer, adding 1 mu L of the diluted enzyme solution into buffer systems with different pH values of 4.0, 5.0, 6.0, 7.4, 8.0, 8.4 and 9.0, incubating for 1h at 4 ℃, and determining the residual enzyme activity, wherein the result shows (as shown in figure 4) that the enzyme has the best stability in the pH range of 8.0-8.4, and the relative enzyme activity can be kept above 96%.
5) Evaluation of temperature stability of Feruloyl esterase
Diluting the original enzyme solution by 3 times with molecular sieve buffer, incubating at 4 deg.C, 20 deg.C, 30 deg.C, 40 deg.C, 50 deg.C and 60 deg.C for 15min, 30min, 1h, 2h, 4h and 6h, respectively, and measuring the residual enzyme activity at each time point, the result shows (as shown in FIG. 5) that the enzyme has good thermal stability at 50 deg.C or lower.
6) Feruloyl esterase tolerance assessment for ions and organic solvents
The relative activity of the enzyme was determined after diluting the original enzyme solution 3 times with molecular sieve buffer and incubating in metal ions and organic solvent at 0.1M or 1% (as shown in FIG. 6) for 15min, and the results showed that Mg2+Has remarkable promoting effect on the enzyme, Na+、Ca2+、Sn2+Ions and EDTA have obvious promotion effect, SDS has obvious inhibition effect on the enzyme, and other ions and reagents have little or no influence.
7) K of feruloyl esterasem、kcatValue measurement and calculation
The Mie constant K of the purified feruloyl esterase (shown in FIG. 7) was measured by using p-nitrophenyl butyrate (pNPB) as a substratemValue 0.38mM, conversion number kcatThe value is 1.57s-1,kcat/KmThe value was 4.11s-1mM-1。
EXAMPLE 4 preparation of Ferulic acid by enzymatic hydrolysis
Substrate pretreatment:
1. pulverizing testa Tritici into powder, soaking in 0.25% potassium acetate at 95 deg.C for 10min, washing with large amount of water until pH is 7, repeating the steps twice, oven drying, sieving with 60 mesh sieve, and weighing.
2. Pulverizing brewer's grains, soaking in 85% ethanol, boiling for 10min, cooling, filtering, repeating the steps twice, sequentially washing with anhydrous ethanol and diethyl ether, oven drying, sieving with 60 mesh sieve, and weighing.
3. The corn cob is dried at 105 ℃ after being subjected to steam explosion treatment, and weighed after being screened by a 60-mesh sieve.
4. The corn stalks are dried at 105 ℃ after being subjected to mechanical shearing type superfine grinding treatment, and weighed after being screened by a 60-mesh sieve.
And (3) carrying out enzymolysis reaction: the enzyme catalysis system was carried out in a 50mL closed vessel in a volume of 10 mL. Weighing 10 wt% of pretreatment substrate, adding 1% of xylanase for carrying out enzymolysis for 24h in advance, and then adding 1% of ferulic acid esterase for carrying out enzymolysis for 24h under the conditions of pH8.4, water bath at 40 ℃ and shaking table rotating speed of 200 rmp. Sampling at 0, 2, 4, 6, 8, 12, 16, 20 and 24h, heating for 5min to terminate the reaction, and detecting the ferulic acid release amount in the sample by HPLC. The same procedure was performed with inactivated enzyme solution as a blank.
And (3) product analysis: as shown in FIG. 8, the final amount of FA released by using wheat bran as a substrate is 2.4mg/g, and the conversion rate is 94.86%; the final FA release amount by taking the brewer's grain as a substrate is 3.8mg/g, and the conversion rate is 80.85 percent; the final release amount of the corn cob serving as a substrate is 6.8mg/g, and the conversion rate is 62.96%; the final release amount of the corn straw used as a substrate is 2.65mg/g, and the conversion rate is 94.64%.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Sequence listing
<110> institute for agricultural product processing of Chinese academy of agricultural sciences
<120> preparation of novel high-activity ferulic acid esterase and application thereof in agricultural wastes
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 274
<212> PRT
<213> Dorea formicigenerans
<400> 1
Met Asn Gln Lys Lys Glu Cys Met Asp Val His Val Asn Gly Leu Lys
1 5 10 15
Phe His Val Gln Thr Phe Gly Ser Gly Val Pro Ile Ile Met Ile Met
20 25 30
Gly Leu Gly Ala Pro Gly Asp Lys Trp Lys His Asn Tyr Glu Leu Leu
35 40 45
Ser Lys Trp Phe Trp Cys Ile Val Pro Asp Asn Arg Gly Ala Gly Leu
50 55 60
Ser Asp Lys Pro Glu Ala Glu Ser Tyr Thr Thr Glu Gln Met Ala Asp
65 70 75 80
Asp Ile Ile Gly Ile Met Asp Ala Leu Asp Ile Lys Lys Ala His Val
85 90 95
Met Gly Val Ser Met Gly Gly Ala Ile Ala Gln Gln Val Ala Leu Lys
100 105 110
Val Pro Asp Arg Val Leu Ser Leu Ile Leu Thr Ser Thr Phe Ala Ser
115 120 125
Val Ser Pro Ala Phe Lys Lys Ala Leu Asn Leu Ile Cys Glu Leu Lys
130 135 140
Glu Asp Thr Asp Pro Ala Val Leu Lys Gln Leu Asn Leu Trp Met Thr
145 150 155 160
Tyr Gly Gln Tyr Thr Gln Ile His His Pro Glu Lys Ile Glu Lys Ser
165 170 175
Ile Glu Glu Asp Ala Ala Tyr Pro Tyr Pro Met Pro Val Tyr Ala Tyr
180 185 190
Lys Ala Gln Cys Gly Ala Cys Leu Ser His Asn Thr Ala Gly Arg Leu
195 200 205
His Glu Leu Lys Met Pro Val Leu Ile Ala Ala Gly Ala Lys Asp Leu
210 215 220
Phe Met Asn Ile Glu Lys Thr Met Glu Leu Val His Gly Ile Pro Gln
225 230 235 240
Ala Glu Phe Tyr Leu Ala Pro Glu Gly Gly His Val His Gln Trp Glu
245 250 255
Tyr Pro Glu Pro Tyr Asp Ser Val Val Val Gly Phe Leu Met Lys His
260 265 270
Thr Asn
<210> 2
<211> 837
<212> DNA
<213> Artificial sequence
<400> 2
ggatccatga accagaaaaa agaatgcatg gacgtgcatg tgaacggcct gaaatttcat 60
gtgcagacct ttggtagcgg cgtgccgatt attatgatta tgggcttagg cgcgcctggc 120
gataaatgga aacacaacta tgaactgctg agcaaatggt tttggtgcat tgtgccggat 180
aatcgcggtg cgggcttaag cgataaaccg gaagcggaaa gctataccac cgaacagatg 240
gcggatgata ttattggcat tatggacgcg ctggatatta aaaaagcgca tgtgatgggc 300
gttagcatgg gtggtgcgat tgcacagcag gttgcgttaa aagtgccgga tcgcgtgtta 360
agcctgattc tgaccagcac ctttgcgtca gttagcccgg cgtttaaaaa agcgctgaac 420
ctgatttgcg aactgaaaga agataccgat ccggcggtgc tgaaacaact gaacctgtgg 480
atgacctatg gccagtatac ccagattcat cacccggaga aaatcgaaaa gagcatcgaa 540
gaagatgcgg cgtatccgta tccgatgccg gtgtatgcgt ataaagcgca atgcggcgcg 600
tgcttaagcc ataataccgc gggtcgcctg catgaactga aaatgccggt gttaattgcg 660
gcgggcgcga aagatctgtt tatgaacatc gagaagacca tggaactggt gcatggcatt 720
ccgcaggcgg aattttatct ggcgccggaa ggcggtcatg ttcatcagtg ggaatatccg 780
gaaccgtatg atagcgtggt ggtgggcttt ctgatgaaac acaccaactg actcgag 837
Claims (10)
1. A gene for expressing feruloyl esterase, which is characterized in that the nucleotide sequence of the gene is shown as SEQ ID NO: 2, respectively.
2. A DfFAE protein encoded by a ferulic acid esterase expression gene according to claim 1, wherein the amino acid sequence of the DfFAE protein is as set forth in SEQ ID NO: 1 is shown.
3. A recombinant expression vector comprising the ferulic acid esterase according to claim 1.
4. The recombinant expression vector according to claim 3, wherein the recombinant expression vector is obtained by inserting the gene expressing feruloyl esterase between the cleavage sites BamHI and XhoI of expression plasmid pET-28 a.
5. A recombinant genetically engineered bacterium, wherein the engineered bacterium is constructed by transforming the recombinant expression vector of claim 3 or 4 into an Escherichia coli host BL21(DE 3).
6. Use of the ferulic acid esterase according to claim 1 for in vitro expression of a DfFAE protein.
7. The use of claim 6, wherein the method for expressing the gene of ferulic acid esterase to express DfFAE protein in vitro comprises the following steps:
(1) cloning to obtain the gene of claim 1, and inserting the gene between enzyme cutting sites BamHI and XhoI of expression plasmid pET-28a (+) to obtain a recombinant expression vector pET-28a (+) -Dffae;
(2) transforming the recombinant expression vector pET-28a (+) -Dffae into competent cells BL21(DE3) through heat shock, and screening to obtain recombinant genetic engineering bacteria;
(3) culturing the genetically engineered bacteria at 37 deg.C, and culturing to obtain bacterial liquid OD600When the value reaches 0.8, cooling to 18 ℃, inducing by using isopropyl thiogalactopyranoside (IPTG) for 14h at 18 ℃, crushing thalli by using a high-pressure homogenization method, and purifying the supernatant of the bacterial liquid by using an affinity chromatography column, an ion column chromatography column and a molecular exclusion chromatography column in sequence to obtain the ferulic acid esterase enzyme liquid.
8. Use of the ferulic acid esterase expression gene of claim 1 for producing functional phenolic acid by enzymatic hydrolysis.
9. The use of claim 8, wherein the functional phenolic acid comprises ferulic acid, coumaric acid, sinapic acid, and the material comprises methyl ferulate, methyl coumarate, methyl sinapinate.
10. The use according to claim 8, wherein the enzymatic production process comprises contacting the relevant substrate with the protein of claim 2 under enzymatic reaction conditions comprising: the temperature is 20-70 deg.C, pH is 4.5-10.0, and the time is 30 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110540431.7A CN113234742A (en) | 2021-05-18 | 2021-05-18 | Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110540431.7A CN113234742A (en) | 2021-05-18 | 2021-05-18 | Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113234742A true CN113234742A (en) | 2021-08-10 |
Family
ID=77135021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110540431.7A Pending CN113234742A (en) | 2021-05-18 | 2021-05-18 | Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113234742A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101402947A (en) * | 2008-11-20 | 2009-04-08 | 中国农业大学 | Novel gene of esterase and recombinant expression system |
CN102732539A (en) * | 2012-06-14 | 2012-10-17 | 中山大学 | Novel esterase and its application |
CN109652392A (en) * | 2019-02-20 | 2019-04-19 | 南京农业大学 | A kind of feruloyl esterase and its preparation method and application |
US20190290675A1 (en) * | 2016-12-06 | 2019-09-26 | Kaleido Biosciences, Inc. | Glycan polymers and related methods thereof |
-
2021
- 2021-05-18 CN CN202110540431.7A patent/CN113234742A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101402947A (en) * | 2008-11-20 | 2009-04-08 | 中国农业大学 | Novel gene of esterase and recombinant expression system |
CN102732539A (en) * | 2012-06-14 | 2012-10-17 | 中山大学 | Novel esterase and its application |
US20190290675A1 (en) * | 2016-12-06 | 2019-09-26 | Kaleido Biosciences, Inc. | Glycan polymers and related methods thereof |
CN109652392A (en) * | 2019-02-20 | 2019-04-19 | 南京农业大学 | A kind of feruloyl esterase and its preparation method and application |
Non-Patent Citations (3)
Title |
---|
GENBANK DATABASE: "alpha/beta hydrolase [Dorea formicigenerans]NCBI Reference Sequence: WP_117657856", 《NCBI》, 5 September 2018 (2018-09-05), pages 117657856 * |
XUE WEI等: "The α-helical cap domain of a novel esterase from gut Alistipes shahii shaping the substrate-binding pocket", 《J AGRIC FOOD CHEM》, vol. 69, no. 21, 12 May 2021 (2021-05-12), pages 1 * |
张浩雯等: "人体肠道菌群来源碳水化合物活性酶(CAZYmes)研究进展", 《生物化学与生物物理进展》, vol. 47, no. 7, 20 July 2020 (2020-07-20), pages 607 - 625 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104169417B (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
AU2011239257B2 (en) | polypeptides having glucoamylase activity and polynucleotides encoding same | |
AU2010276468B2 (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
EP2638154B1 (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
Xu et al. | Extracellular secretion of feruloyl esterase derived from Lactobacillus crispatus in Escherichia coli and its application for ferulic acid production | |
AU2010276470B2 (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
CN108949852B (en) | Method for preparing xylitol by whole-cell catalysis | |
CN109735518B (en) | Beta-glucuronidase mutant with optimum reaction pH value increased and glycyrrhizic acid conversion process thereof | |
CN112813051A (en) | Low-temperature inulase exonuclease mutant MutP124G with improved heat adaptability and application thereof | |
US8728768B2 (en) | Polypeptides having isoamylase activity and methods of use | |
CN114410611B (en) | Kunmu polysaccharide degrading enzyme OUC-BsLam26 and application thereof | |
CN110656098B (en) | Application of acetyl esterase in promoting degradation of beta-mannase on acetylated mannan | |
CA2780974C (en) | Mutli-cellulase enzyme compositions for hydrolysis of cellulosic biomass | |
Ximenes et al. | Enzyme production by industrially relevant fungi cultured on coproduct from corn dry grind ethanol plants | |
KR20100040438A (en) | A novel agarase and an enzymatic production method of agarooligosaccharide from agarose using the same | |
US9617527B2 (en) | Polypeptides having glucoamylase activity and polynucleotides encoding same | |
CN109355274B (en) | Beta-glucosidase with improved resistance to trypsin and pepsin | |
CN113234742A (en) | Preparation of novel high-activity ferulic acid esterase and application of novel high-activity ferulic acid esterase in agricultural wastes | |
CN1245507C (en) | High temperaturebeta- glucosaccharase, coding gene and uses thereof | |
CN110004099B (en) | Fermentation production method of salidroside | |
WO2022062088A1 (en) | Genetically engineered bacterium for transforming lignin-containing biomass to synthesize vanillin and use thereof | |
CN111254152B (en) | Acetylxylan esterase gene, coded product and preparation method thereof | |
CN111466511B (en) | Compositions containing a desepoxyprotease and methods of detoxification | |
CN1223676C (en) | High temperaturealpha- amylase and coding gene thereof | |
CN109504669B (en) | Beta-glucosidase with improved resistance to trypsin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210810 |